What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
about
Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis.Venous thromboembolism in amyotrophic lateral sclerosis: a prospective study.Successful use of Alteplase during cardiopulmonary resuscitation following massive PE in a patient presenting with ischaemic stroke and haemorrhagic transformation.Assessment of Venous Thromboembolism Prophylaxis in Neurological Patients with Restricted Mobility - VTE-NEURO Study.Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Clinical features and risk factor analysis for lower extremity deep venous thrombosis in Chinese neurosurgical patients.Primary prevention of venous thromboembolism in elderly medical patientsPulmonary embolism in ischemic stroke: clinical presentation, risk factors, and outcomeIschemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.Intracerebral hemorrhage specific intensity of care quality metrics.Causes of death among persons who survive an acute ischemic stroke.Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.DVT Prevention in Stroke.Deep Vein Thrombosis in Acute Stroke - A Systemic Review of the Literature.Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage.
P2860
Q33306744-5BFDA1EA-6C82-4706-B4B4-674DFCA02372Q33654597-14557737-A58E-45EA-BD62-D4A2998D5D59Q34439225-B04ACD18-33D2-44CE-A5D6-3AC8E382B3E7Q34717177-18C6F3C8-E6E4-402D-B2AE-0255BC2A8700Q35752603-DAD31E1E-FB58-4428-B061-9BD297D725E7Q36406650-B6B2297D-455D-467C-BAC1-8EBE3E2F7F3EQ37316796-2CBD198D-B081-4218-9443-1947A1087040Q37457766-E9AF1C79-6D2D-45F3-B2EB-D2CDBD7C7EC4Q37556055-30E01D87-D97D-4493-9A51-23E6545CBE3CQ37809772-C9F9F7D5-AE61-439F-9DE8-F7C66706595CQ38222122-A86E0D97-ACAF-4991-9C1B-76E6757F3C63Q47396348-3774C74E-99A1-4868-BAC0-1F9390CE8575Q47833921-9FE5FC24-69CE-4575-8BC5-5068F689A346Q47969674-3FEBD702-5399-44AF-BC10-D0E0C7221927Q52674793-A1FB68EE-5119-4EC8-B01F-E310D1DAB227Q53079755-1C158AA4-D843-41E0-90A5-A8A21CE30F10
P2860
What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
What is the optimal pharmacolo ...... ts with acute ischemic stroke?
@ast
What is the optimal pharmacolo ...... ts with acute ischemic stroke?
@en
type
label
What is the optimal pharmacolo ...... ts with acute ischemic stroke?
@ast
What is the optimal pharmacolo ...... ts with acute ischemic stroke?
@en
prefLabel
What is the optimal pharmacolo ...... ts with acute ischemic stroke?
@ast
What is the optimal pharmacolo ...... ts with acute ischemic stroke?
@en
P1433
P1476
What is the optimal pharmacolo ...... ts with acute ischemic stroke?
@en
P2093
Giancarlo Agnelli
Pieter W Kamphuisen
P304
P356
10.1016/J.THROMRES.2006.03.010
P577
2006-05-03T00:00:00Z